Skip to main content
. 2020 Nov 22;28(2):579–586. doi: 10.1111/ene.14597

Table 1.

Characteristics of cases and controls

n Cases n Controls p
All
Sex (M/F), % 670 16/84 670 16/84
Age at sampling, years 25 (21–29) 25 (21–29) 0.97
Age at disease onset, years 33 (28–40) n.a.
Time from sampling until disease onset, years 8 (4–13) n.a.
Age group < 20 years
Sex (M/F), % 143 23/77 143 23/77
Age at sampling, years 18 (14–19) 18 (14–19) 0.82
Age at disease onset, years 26 (22–31) n.a.
Time from sampling until disease onset, years 10 (6–16) n.a.
Age group 20–29 years
Sex (M/F), % 376 14/86 376 14/86
Age at sampling, years 25 (22–27) 25 (23–27) 0.89
Age at disease onset, years 33 (29–38) n.a.
Time from sampling until disease onset, years 8 (3–13) n.a.
Age group 30–39 years
Sex (M/F), % 151 15/85 151 15/85
Age at sampling, years 33 (31–35) 33 (31–35) 0.72
Age at disease onset, years 40 (37–43) n.a.
Time from sampling until disease onset, years 6 (3–10) n.a.
Biobank
Umeå 102 15.2 % 102 15.2 %
PHAS 139 20.8 % 139 20.8 %
Örebro 29 4.3 % 29 4.3 %
Göteborg 47 7.0 % 47 7.0 %
Skåne 314 46.9 % 314 46.9 %
Linköping 39 5.8 % 39 5.8 %

Values expressed as a percentage for proportions and median (interquartile range) for continuous variables. p values were calculated with the Mann–Whitney U test.

Abbreviation: PHAS, Public Health Agency of Sweden.